{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T02:09:15Z","timestamp":1778119755422,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1038\/s41433-024-03057-6","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T15:02:12Z","timestamp":1712761332000},"page":"1845-1854","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mesenchymal stem cell based therapies for uveitis: a systematic review of preclinical studies"],"prefix":"10.1038","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0877-5631","authenticated-orcid":false,"given":"Pushpinder","family":"Kanda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jobanpreet","family":"Dhillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deeksha","family":"Kundapur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1336-3866","authenticated-orcid":false,"given":"Chloe C.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,10]]},"reference":[{"key":"3057_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.iio.0000155938.83083.94","volume":"45","author":"D Wakefield","year":"2005","unstructured":"Wakefield D, Chang JH. Epidemiology of uveitis. Int Ophthalmol Clin. 2005;45:1\u201313.","journal-title":"Int Ophthalmol Clin"},{"key":"3057_CR2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.5301\/ejo.5000278","volume":"23","author":"E Miserocchi","year":"2013","unstructured":"Miserocchi E, Fogliato G, Modorati G, Bandello F. Review on the worldwide epidemiology of uveitis. Eur J Ophthalmol. 2013;23:705\u201317.","journal-title":"Eur J Ophthalmol"},{"key":"3057_CR3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4103\/0301-4738.114099","volume":"61","author":"K Babu","year":"2013","unstructured":"Babu K, Mahendradas P. Medical management of uveitis - current trends. Indian J Ophthalmol. 2013;61:277\u201383.","journal-title":"Indian J Ophthalmol"},{"key":"3057_CR4","first-page":"1381","volume":"9","author":"PT Zhao","year":"2016","unstructured":"Zhao PT, Zhang LJ, Shao H, Bai LL, Yu B, Su C, et al. Therapeutic effects of mesenchymal stem cells administered at later phase of recurrent experimental autoimmune uveitis. Int J Ophthalmol. 2016;9:1381\u20139.","journal-title":"Int J Ophthalmol"},{"key":"3057_CR5","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1177\/0963689718796196","volume":"27","author":"J Li","year":"2018","unstructured":"Li J, Qiu C, Zhang Z, Yuan W, Ge Z, Tan B, et al. Subretinal transplantation of human amniotic epithelial cells in the treatment of autoimmune uveitis in rats. Cell Transpl. 2018;27:1504\u201314.","journal-title":"Cell Transpl"},{"key":"3057_CR6","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1167\/iovs.14-14788","volume":"55","author":"L Zhang","year":"2014","unstructured":"Zhang L, Zheng H, Shao H, Nian H, Zhang Y, Bai L, et al. Long-term therapeutic effects of mesenchymal stem cells compared to dexamethasone on recurrent experimental autoimmune uveitis of rats. Investig Ophthalmol Vis Sci. 2014;55:5561\u201371.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3057_CR7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s13287-022-03054-0","volume":"13","author":"R Margiana","year":"2022","unstructured":"Margiana R, Markov A, Zekiy AO, Hamza MU, Al-Dabbagh KA, Al-Zubaidi SH, et al. Clinical application of mesenchymal stem cell in regenerative medicine: a narrative review. Stem Cell Res Ther. 2022;13:366.","journal-title":"Stem Cell Res Ther"},{"key":"3057_CR8","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1080\/14712598.2017.1346080","volume":"17","author":"P Kanda","year":"2017","unstructured":"Kanda P, Davis DR. Cellular mechanisms underlying cardiac engraftment of stem cells. Expert Opin Biol Ther. 2017;17:1127\u201343.","journal-title":"Expert Opin Biol Ther"},{"key":"3057_CR9","volume":"6","author":"O Levy","year":"2020","unstructured":"Levy O, Kuai R, Siren EMJ, Bhere D, Milton Y, Nissar N, et al. Shattering barriers toward clinically meaningful MSC therapies. Sci Adv. 2020;6:eaba6884.","journal-title":"Sci Adv"},{"key":"3057_CR10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13287-022-02780-9","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, Ren X, Zhang Z, Duan Y, Li H, Chen S, et al. Effect of small extracellular vesicles derived from IL-10-overexpressing mesenchymal stem cells on experimental autoimmune uveitis. Stem Cell Res Ther. 2022;13:100.","journal-title":"Stem Cell Res Ther"},{"key":"3057_CR11","volume":"11","author":"W Wei","year":"2020","unstructured":"Wei W, Ao Q, Wang X, Cao Y, Liu Y, Zheng SG, et al. Mesenchymal stem cell-derived exosomes: a promising biological tool in nanomedicine. Front Pharm. 2020;11:590470.","journal-title":"Front Pharm"},{"key":"3057_CR12","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.","journal-title":"BMJ"},{"key":"3057_CR13","first-page":"84","volume":"4","author":"J Kung","year":"2010","unstructured":"Kung J, Chiappelli F, Cajulis OO, Avezova R, Kossan G, Chew L, et al. From systematic reviews to clinical recommendations for evidence-based health care: validation of Revised Assessment of Multiple Systematic Reviews (R-AMSTAR) for grading of clinical relevance. Open Dent J. 2010;4:84\u201391.","journal-title":"Open Dent J"},{"key":"3057_CR14","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:43.","journal-title":"BMC Med Res Methodol"},{"key":"3057_CR15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012;22:276\u201382.","journal-title":"Biochem Med"},{"key":"3057_CR16","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1167\/iovs.10-6334","volume":"52","author":"X Zhang","year":"2011","unstructured":"Zhang X, Ren X, Li G, Jiao C, Zhang L, Zhao S, et al. Mesenchymal stem cells ameliorate experimental autoimmune uveoretinitis by comprehensive modulation of systemic autoimmunity. Investig Ophthalmol Vis Sci. 2011;52:3143\u201352.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3057_CR17","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1167\/iovs.11-8211","volume":"53","author":"R Tasso","year":"2012","unstructured":"Tasso R, Ilengo C, Quarto R, Cancedda R, Caspi RR, Pennesi G. Mesenchymal stem cells induce functionally active T-regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis. Investig Ophthalmol Vis Sci. 2012;53:786\u201393.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3057_CR18","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/09273948.2017.1343356","volume":"26","author":"Y Qin","year":"2018","unstructured":"Qin Y, Chan AM, Chang YL, Matynia A, Kouris NA, Kimbrel EA, et al. Human embryonic stem cell-derived mesenchymal stromal cells decrease the development of severe experimental autoimmune Uveitis in B10.RIII Mice. Ocul Immunol Inflamm. 2018;26:1228\u201336.","journal-title":"Ocul Immunol Inflamm"},{"key":"3057_CR19","first-page":"624640","volume":"2014","author":"JY Oh","year":"2014","unstructured":"Oh JY, Kim TW, Jeong HJ, Lee HJ, Ryu JS, Wee WR, et al. Intraperitoneal infusion of mesenchymal stem\/stromal cells prevents experimental autoimmune uveitis in mice. Mediat Inflamm. 2014;2014:624640.","journal-title":"Mediat Inflamm"},{"key":"3057_CR20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/cei.12080","volume":"173","author":"G Li","year":"2013","unstructured":"Li G, Yuan L, Ren X, Nian H, Zhang L, Han ZC, et al. The effect of mesenchymal stem cells on dynamic changes of T cell subsets in experimental autoimmune uveoretinitis. Clin Exp Immunol. 2013;173:28\u201337.","journal-title":"Clin Exp Immunol"},{"key":"3057_CR21","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.4049\/jimmunol.1402139","volume":"194","author":"HJ Lee","year":"2015","unstructured":"Lee HJ, Ko JH, Jeong HJ, Ko AY, Kim MK, Wee WR, et al. Mesenchymal stem\/stromal cells protect against autoimmunity via CCL2-dependent recruitment of myeloid-derived suppressor cells. J Immunol. 2015;194:3634\u201345.","journal-title":"J Immunol"},{"key":"3057_CR22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1073\/pnas.1522905113","volume":"113","author":"JH Ko","year":"2016","unstructured":"Ko JH, Lee HJ, Jeong HJ, Kim MK, Wee WR, Yoon SO, et al. Mesenchymal stem\/stromal cells precondition lung monocytes\/macrophages to produce tolerance against allo- and autoimmunity in the eye. Proc Natl Acad Sci USA. 2016;113:158\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3057_CR23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/scd.2015.0227","volume":"25","author":"X Chen","year":"2016","unstructured":"Chen X, Shao H, Zhi Y, Xiao Q, Su C, Dong L, et al. CD73 pathway contributes to the immunosuppressive ability of mesenchymal stem cells in intraocular autoimmune responses. Stem Cells Dev. 2016;25:337\u201346.","journal-title":"Stem Cells Dev"},{"key":"3057_CR24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/term.3259","volume":"16","author":"Y Mu","year":"2022","unstructured":"Mu Y, Xu W, Liu J, Wang Y, Chen J, Zhou Q. Mesenchymal stem cells moderate experimental autoimmune uveitis by dynamic regulating Th17 and Breg cells response. J Tissue Eng Regen Med. 2022;16:26\u201335.","journal-title":"J Tissue Eng Regen Med"},{"key":"3057_CR25","volume":"7","author":"L Bai","year":"2017","unstructured":"Bai L, Shao H, Wang H, Zhang Z, Su C, Dong L, et al. Effects of mesenchymal stem cell-derived exosomes on experimental autoimmune uveitis. Sci Rep. 2017;7:4323.","journal-title":"Sci Rep."},{"key":"3057_CR26","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3389\/fimmu.2020.01051","volume":"11","author":"M Kang","year":"2020","unstructured":"Kang M, Choi JK, Jittayasothorn Y, Egwuagu CE. Interleukin 35-Producing exosomes suppress neuroinflammation and autoimmune uveitis. Front Immunol. 2020;11:1051.","journal-title":"Front Immunol"},{"key":"3057_CR27","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.stemcr.2017.04.008","volume":"8","author":"T Shigemoto-Kuroda","year":"2017","unstructured":"Shigemoto-Kuroda T, Oh JY, Kim DK, Jeong HJ, Park SY, Lee HJ, et al. MSC-derived extracellular vesicles attenuate immune responses in two autoimmune murine models: Type 1 diabetes and uveoretinitis. Stem Cell Rep. 2017;8:1214\u201325.","journal-title":"Stem Cell Rep."},{"key":"3057_CR28","first-page":"15.16.1","volume":"15","author":"RR Caspi","year":"2003","unstructured":"Caspi RR. Experimental autoimmune uveoretinitis in the rat and mouse. Curr Protoc Immunol. 2003;15:15.16.1\u201320.","journal-title":"Curr Protoc Immunol"},{"key":"3057_CR29","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1089\/jir.2011.0042","volume":"31","author":"R Horai","year":"2011","unstructured":"Horai R, Caspi RR. Cytokines in autoimmune uveitis. J Interferon Cytokine Res. 2011;31:733\u201344.","journal-title":"J Interferon Cytokine Res"},{"key":"3057_CR30","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1089\/jop.2016.0165","volume":"33","author":"A Foussat","year":"2017","unstructured":"Foussat A, Gregoire S, Clerget-Chossat N, Terrada C, Asnagli H, Lemoine FM, et al. Regulatory T Cell therapy for uveitis: a new promising challenge. J Ocul Pharm Ther. 2017;33:278\u201384.","journal-title":"J Ocul Pharm Ther"},{"key":"3057_CR31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.21037\/sci-2020-037","volume":"8","author":"S Muthu","year":"2021","unstructured":"Muthu S, Bapat A, Jain R, Jeyaraman N, Jeyaraman M. Exosomal therapy-a new frontier in regenerative medicine. Stem Cell Investig. 2021;8:7.","journal-title":"Stem Cell Investig"},{"key":"3057_CR32","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-020-02622-3","volume":"18","author":"S Nikfarjam","year":"2020","unstructured":"Nikfarjam S, Rezaie J, Zolbanin NM, Jafari R. Mesenchymal stem cell derived-exosomes: a modern approach in translational medicine. J Transl Med. 2020;18:449.","journal-title":"J Transl Med"},{"key":"3057_CR33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jtos.2020.11.013","volume":"19","author":"M Moller-Hansen","year":"2021","unstructured":"Moller-Hansen M, Larsen AC, Toft PB, Lynggaard CD, Schwartz C, Bruunsgaard H, et al. Safety and feasibility of mesenchymal stem cell therapy in patients with aqueous deficient dry eye disease. Ocul Surf. 2021;19:43\u201352.","journal-title":"Ocul Surf"},{"key":"3057_CR34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.trsl.2018.11.003","volume":"206","author":"M Calonge","year":"2019","unstructured":"Calonge M, Perez I, Galindo S, Nieto-Miguel T, Lopez-Paniagua M, Fernandez I, et al. A proof-of-concept clinical trial using mesenchymal stem cells for the treatment of corneal epithelial stem cell deficiency. Transl Res. 2019;206:18\u201340.","journal-title":"Transl Res"},{"key":"3057_CR35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13287-020-1549-6","volume":"11","author":"E Ozmert","year":"2020","unstructured":"Ozmert E, Arslan U. Management of retinitis pigmentosa by Wharton\u2019s jelly derived mesenchymal stem cells: preliminary clinical results. Stem Cell Res Ther. 2020;11:25.","journal-title":"Stem Cell Res Ther"},{"key":"3057_CR36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12015-021-10231-w","volume":"18","author":"U Galderisi","year":"2022","unstructured":"Galderisi U, Peluso G, Di Bernardo G. Clinical trials based on mesenchymal stromal cells are exponentially increasing: where are we in recent years? Stem Cell Rev Rep. 2022;18:23\u201336.","journal-title":"Stem Cell Rev Rep."},{"key":"3057_CR37","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/IAE.0b013e3181f9c242","volume":"31","author":"RC Siqueira","year":"2011","unstructured":"Siqueira RC, Messias A, Voltarelli JC, Scott IU, Jorge R. Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase I trial. Retina. 2011;31:1207\u201314.","journal-title":"Retina"},{"key":"3057_CR38","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13287-016-0432-y","volume":"7","author":"A Oner","year":"2016","unstructured":"Oner A, Gonen ZB, Sinim N, Cetin M, Ozkul Y. Subretinal adipose tissue-derived mesenchymal stem cell implantation in advanced stage retinitis pigmentosa: a phase I clinical safety study. Stem Cell Res Ther. 2016;7:178.","journal-title":"Stem Cell Res Ther"},{"key":"3057_CR39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13287-016-0299-y","volume":"7","author":"M Ezquer","year":"2016","unstructured":"Ezquer M, Urzua CA, Montecino S, Leal K, Conget P, Ezquer F. Intravitreal administration of multipotent mesenchymal stromal cells triggers a cytoprotective microenvironment in the retina of diabetic mice. Stem Cell Res Ther. 2016;7:42.","journal-title":"Stem Cell Res Ther"},{"key":"3057_CR40","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/sctm.19-0044","volume":"8","author":"I Mastrolia","year":"2019","unstructured":"Mastrolia I, Foppiani EM, Murgia A, Candini O, Samarelli AV, Grisendi G, et al. Challenges in clinical development of mesenchymal stromal\/stem cells: concise review. Stem Cells Transl Med. 2019;8:1135\u201348.","journal-title":"Stem Cells Transl Med"},{"key":"3057_CR41","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.stem.2022.04.002","volume":"29","author":"BN Kharbikar","year":"2022","unstructured":"Kharbikar BN, Mohindra P, Desai TA. Biomaterials to enhance stem cell transplantation. Cell Stem Cell. 2022;29:692\u2013721.","journal-title":"Cell Stem Cell"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03057-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03057-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03057-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T14:46:49Z","timestamp":1720190809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03057-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,10]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["3057"],"URL":"https:\/\/doi.org\/10.1038\/s41433-024-03057-6","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,10]]},"assertion":[{"value":"25 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}